
Tataiso ena e fana ka kakaretso ea kakaretso ea phekolo ea kankere ea matšoafo ea phetoho ea liphatsa tsa lefutso dikgetho tse fumanehang lipetleleng tse ka sehloohong. Re hlahloba tsoelopele ea morao-rao ea liphekolo tse lebisitsoeng le immunotherapy, re totobatsa bohlokoa ba merero ea kalafo ea motho ka mong e ipapisitseng le profiling ea lefutso. Ithute ka ho tsebahatsa lipetlele tse tsebahalang tse sebetsanang le tsona phekolo ea kankere ea matšoafo ea phetoho ea liphatsa tsa lefutso, ho utloisisa mokhoa oa phekolo, le ho tsamaisa mathata a lefu lena le rarahaneng.
Kankere ea matšoafo ke lefu le rarahaneng, 'me phetoho ea liphatsa tsa lefutso e phetha karolo ea bohlokoa ho nts'etsopele le tsoelo-pele ea eona. Liphetoho tse fapaneng tsa liphatsa tsa lefutso li ka lebisa mefuteng e fapaneng ea mofetše oa matšoafo, tse amang katleho ea liphekolo tse fapaneng. Ho utloisisa liphetoho tsena ho bohlokoa bakeng sa ho theha moralo oa kalafo o ikhethileng. Ka mohlala, liphetoho tsa EGFR li atisa ho lebisoa ke mekhoa e itseng ea phekolo. Khethollo ea liphetoho tsena hangata ke mohato oa pele oa ho fumana mokhoa o sebetsang ka ho fetisisa oa ho sebetsa phekolo ea kankere ea matšoafo ea phetoho ea liphatsa tsa lefutso.
Liphetoho tse 'maloa tsa bohlokoa tsa liphatsa tsa lefutso li amahanngoa le mofetše oa matšoafo, ho kenyelletsa EGFR, ALK, ROS1, BRAF, le tse ling. Phetoho e 'ngoe le e' ngoe e ama kholo le ho ata ha lisele tsa mofetše ka tsela e fapaneng. Teko e tsoetseng pele ea liphatsa tsa lefutso e bohlokoa ho tseba phetoho e itseng e tsamaisang mofetše oa mokuli.
Liphetoho tsa EGFR li atisa ho hlokomeloa ho bakuli ba kankere ea matšoafo, haholo-holo ba sa kang ba tsuba. Liphekolo tse 'maloa tse lebisitsoeng, joalo ka tyrosine kinase inhibitors (TKIs), li etselitsoe ho thibela ts'ebetso ea protheine ea EGFR e fetotsoeng, ho liehisa kapa ho emisa kholo ea mofets'e. Hangata meriana ena e mamelloa hantle, e leng se etsang hore ho be le ntlafatso e kholo bophelong ba kakaretso. Mehlala ea EGFR TKIs e kenyelletsa gefitinib, erlotinib, le afatinib.
Ho tšoana le liphetoho tsa EGFR, ALK le ROS1 rearrangement le tsona ke lipheo tse ka etsoang. Li-TKI tse khethehileng li teng ho lebisa tlhokomelo ea liphetoho tsena tsa liphatsa tsa lefutso, tse fanang ka mekhoa e sebetsang ea phekolo bakeng sa bakuli ba nang le liphetoho tsena tsa lefutso. Liphekolo tse ling tse lebisitsoeng ho tsona li ntse li ntlafatsoa bakeng sa liphetoho tse fapaneng tsa lefutso, tse fanang ka tšepo bakeng sa liphetho tse ntlafalitsoeng phekolo ea kankere ea matšoafo ea phetoho ea liphatsa tsa lefutso. Khetho ea phekolo e nepahetseng e itšetlehile haholo ka lintlha tse tobileng tsa lefutso la motho ka mong.
Immunotherapy e emela katleho e kholo kalafong ea mofetše. Liphekolo tsena li sebetsa ka ho susumetsa sesole sa 'mele sa mokuli ho lemoha le ho hlasela lisele tsa mofetše. Lisebelisoa tse khethehileng tsa immunotherapy, tse kang checkpoint inhibitors, li bontšitse katleho e tsotehang ho phekoleng bakuli ba nang le liphetoho tse itseng tsa lefutso mofetšeng oa matšoafo. Lithethefatsi tsena hangata li sebelisoa hammoho le litlhare tse lebisitsoeng ho fumana liphello tse ntle.
Khetho ea phekolo ea immunotherapy e itšetlehile ka lintlha tse sa tšoaneng, ho akarelletsa le mofuta oa phetoho ea liphatsa tsa lefutso, boemo ba kankere, le bophelo bo botle ba mokuli ka kakaretso. Ho nahanela ka hloko le tlhahlobo ea motho ka mong ke tsa bohlokoa bakeng sa ho etsa liqeto tse nang le tsebo mabapi le mokhoa o nepahetseng oa immunotherapy bakeng sa mokuli. phekolo ea kankere ea matšoafo ea phetoho ea liphatsa tsa lefutso.
Ho khetha sepetlele se nepahetseng ke habohlokoa bakeng sa katleho phekolo ea kankere ea matšoafo ea phetoho ea liphatsa tsa lefutso. Batla lipetlele tse nang le phihlelo e kholo ea ho phekola mofetše oa matšoafo, haholo-holo tse nang le mananeo a khethehileng a shebaneng le phekolo ea limolek'hule le immunotherapy. Ho ba teng ha bokhoni bo tsoetseng pele ba tlhahlobo ea liphatsa tsa lefutso le sehlopha sa litsebi tse fapaneng tsa oncologists, lingaka tse buoang, le litsebi tse ling le tsona ke tsa bohlokoa. Nahana ka lintlha tse kang litlhahlobo tsa mokuli, litekanyetso tsa katleho, le boleng bo akaretsang ba tlhokomelo e fanoang.
Mokhoa o fapaneng o kenyelletsang lingaka tsa oncologists, lingaka tse buoang, lingaka tsa mafu, radiologists le litsebi tse ling o bohlokoa bakeng sa katleho. phekolo ea kankere ea matšoafo ea phetoho ea liphatsa tsa lefutso. Mokhoa ona oa tšebelisano o lumella tlhahlobo e felletseng, moralo oa kalafo oa motho ka mong, le tlhokomelo e hokahaneng leetong lohle la mokuli.
| Ntlha | Ho nahanela |
|---|---|
| Boiphihlelo ka Liphekolo tse Lebisitsoeng | Batla lipetlele tse nang le tlaleho e netefalitsoeng ea katleho ea ho sebelisa liphekolo tse lebisitsoeng bakeng sa liphetoho tse itseng tsa lefutso. |
| Tlhahlobo e tsoetseng pele ea liphatsa tsa lefutso | Netefatsa hore sepetlele se fana ka tlhahlobo e felletseng ea liphatsa tsa lefutso ho tseba ka nepo liphetoho tse teng. |
| Sehlopha sa Multidisciplinary | Khetha lipetlele tse nang le sehlopha sa litsebi tse sebetsang 'moho ho fana ka tlhokomelo e felletseng. |
| Litšebeletso tsa Tšehetso ea Bakuli | Nahana ka boteng ba litšebeletso tsa tlhokomelo ea tšehetso ho thusa bakuli le malapa a bona ho sebetsana ka katleho le mathata a phekolo. |
Bakeng sa bakuli ba batlang tlhokomelo e tsoetseng pele ka phekolo ea kankere ea matšoafo ea phetoho ea liphatsa tsa lefutso, nahana ka litsi tsa lipatlisiso tse kang Setsi sa Lipatlisiso sa Kankere sa Shandong Baofa. Kamehla buisana le ngaka ea hau ho fumana hore na ke mehato efe e nepahetseng bakeng sa maemo a hau.
Boitlhotlhollo: Boitsebiso bona bo reretsoe merero ea thuto feela 'me ha boa lokela ho nkoa e le keletso ea bongaka. Kamehla buisana le mofani oa tlhokomelo ea bophelo bakeng sa tlhahlobo le kalafo ea boemo bofe kapa bofe ba bongaka.
ka thoko>
'mele>